ORKA — Oruka Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Oruka Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -19.3 | -9.93 | -5.34 | -83.7 | -105 |
| Depreciation | |||||
| Non-Cash Items | 0.572 | 0.655 | 0.782 | 14.3 | 19.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.028 | -1.66 | -0.472 | 11.6 | -2.56 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -18.8 | -10.9 | -5.01 | -57.8 | -88.2 |
| Capital Expenditures | -0.043 | -0.002 | 0 | -0.189 | -0.209 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -330 | -96.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.043 | -0.002 | 0 | -330 | -96.7 |
| Financing Cash Flow Items | -0.977 | 0 | 0 | 422 | 170 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.1 | 0 | 0 | 450 | 170 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.29 | -10.9 | -5.01 | 61.6 | -14.6 |